KaloBios Can Get Priority Review Voucher With 505(b)(2) Chagas Application

US FDA’s recent guidance on the program notes that even tropical disease products approved under 505(b)(2) are eligible for a priority review voucher.

Priority Review Voucher

More from US FDA

More from Agency Leadership